![CALCIPOTRIENE 0.005% / DICLOFENAC SODIUM 3% / HYALURONIC ACID SODIUM SALT 2% / NIACINAMIDE 2% CREAM [SINCERUS FLORIDA, LLC]](https://medic.hrt.org//dailymed/images/883e1f59-2a7a-1ccd-e053-2995a90a1ef0/-2 end.jpg)
![CALCIPOTRIENE 0.005% / DICLOFENAC SODIUM 3% / HYALURONIC ACID SODIUM SALT 2% / NIACINAMIDE 2% CREAM [SINCERUS FLORIDA, LLC]](https://medic.hrt.org//dailymed/images/883e1f59-2a7a-1ccd-e053-2995a90a1ef0/2030-2 front.jpg)
![CALCIPOTRIENE 0.005% / DICLOFENAC SODIUM 3% / HYALURONIC ACID SODIUM SALT 2% / NIACINAMIDE 2% CREAM [SINCERUS FLORIDA, LLC]](https://medic.hrt.org//dailymed/images/883e1f59-2a7a-1ccd-e053-2995a90a1ef0/2030-2 middle.jpg)
| NDC | 72934-2030-2 |
| Set ID | 883e1f59-2a7a-1ccd-e053-2995a90a1ef0 |
| Category | HUMAN PRESCRIPTION DRUG LABEL |
| Packager | Sincerus Florida, LLC |
| Generic Name | |
| Product Class | |
| Product Number | |
| Application Number |
- Directions for use
- ADVERSE REACTIONS
- Active, inactive
- NDC 72934-2030-2 CALCIPOTRIENE USP 0.005% / DICLOFENAC SODIUM USP 3% / HYALURONIC ACID SODIUM SALT 2% / NIACINAMIDE USP 2%. Cream 30 gm
-
INGREDIENTS AND APPEARANCE
CALCIPOTRIENE 0.005% / DICLOFENAC SODIUM 3% / HYALURONIC ACID SODIUM SALT 2% / NIACINAMIDE 2%
calcipotriene 0.005% / diclofenac sodium 3% / hyaluronic acid sodium salt 2% / niacinamide 2% creamProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:72934-2030 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength CALCIPOTRIENE (UNII: 143NQ3779B) (CALCIPOTRIENE - UNII:143NQ3779B) CALCIPOTRIENE 0.005 g in 100 g DICLOFENAC SODIUM (UNII: QTG126297Q) (DICLOFENAC - UNII:144O8QL0L1) DICLOFENAC SODIUM 3 g in 100 g HYALURONATE SODIUM (UNII: YSE9PPT4TH) (HYALURONIC ACID - UNII:S270N0TRQY) HYALURONATE SODIUM 2 g in 100 g NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4) NIACINAMIDE 2 g in 100 g Product Characteristics Color white (clear cream) Score Shape Size Flavor Imprint Code Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:72934-2030-2 30 g in 1 BOTTLE, PUMP; Type 0: Not a Combination Product 05/07/2019 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 05/07/2019 Labeler - Sincerus Florida, LLC (080105003) Establishment Name Address ID/FEI Business Operations Sincerus Florida, LLC 080105003 manufacture(72934-2030)
